BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 1678604)

  • 1. Restriction fragment length polymorphisms of the apolipoprotein A-I, C-III, A-IV gene locus. Relationships with lipids, apolipoproteins, and premature coronary artery disease.
    Ordovas JM; Civeira F; Genest J; Craig S; Robbins AH; Meade T; Pocovi M; Frossard PM; Masharani U; Wilson PW
    Atherosclerosis; 1991 Mar; 87(1):75-86. PubMed ID: 1678604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linkage disequilibrium of the Apo AI-CIII-AIV gene cluster and their relationship to plasma triglyceride, apolipoprotein AI and CIII levels in Koreans.
    Song J; Park JW; Park H; Kim JQ
    Mol Cells; 1998 Feb; 8(1):12-8. PubMed ID: 9571626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variation in the apolipoprotein AI-CIII-AIV gene cluster and coronary heart disease.
    Paulweber B; Friedl W; Krempler F; Humphries SE; Sandhofer F
    Atherosclerosis; 1988 Oct; 73(2-3):125-33. PubMed ID: 2903749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The MspI restriction fragment length polymorphism 3' to the apolipoprotein A-II gene: relationships with lipids, apolipoproteins, and premature coronary artery disease.
    Civeira F; Genest J; Pocovi M; Salem DN; Herbert PN; Wilson PW; Schaefer EJ; Ordovas JM
    Atherosclerosis; 1992 Feb; 92(2-3):165-76. PubMed ID: 1352975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation at the apolipoprotein (apo) AI-CIII-AIV gene cluster and apo B gene loci is associated with lipoprotein and apolipoprotein levels in Italian children.
    Xu CF; Nanjee MN; Savill J; Talmud PJ; Angelico F; Del Ben M; Antonini R; Mazzarella B; Miller N; Humphries SE
    Am J Hum Genet; 1990 Sep; 47(3):429-39. PubMed ID: 1975478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restriction fragment length polymorphisms at the apoprotein genes AI, CIII and B-100 and in the 5' flanking region of the insulin gene as possible markers of coronary heart disease.
    Wick U; Witt E; Engel W
    Clin Genet; 1995 Apr; 47(4):184-90. PubMed ID: 7628120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variability gene effects of DNA polymorphisms at the apo B, apo A I/C III and apo E loci on serum lipids: the Cardiovascular Risk in Young Finns Study.
    Porkka KV; Taimela S; Kontula K; Lehtimäki T; Aalto-Setälä K; Akerblom HK; Viikari JS
    Clin Genet; 1994 Mar; 45(3):113-21. PubMed ID: 7913004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of genotypes at the apolipoprotein AI-CIII-AIV, apolipoprotein B and lipoprotein lipase gene loci with coronary atherosclerosis and high density lipoprotein subclasses.
    Peacock RE; Hamsten A; Johansson J; Nilsson-Ehle P; Humphries SE
    Clin Genet; 1994 Oct; 46(4):273-82. PubMed ID: 7834891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein AI-CIII-AIV genetic polymorphisms and coronary heart disease in type 2 diabetes mellitus.
    Rigoli L; Raimondo G; Di Benedetto A; Romano G; Porcellini A; Campo S; Corica F; Riccardi G; Squadrito G; Cucinotta D
    Acta Diabetol; 1995 Dec; 32(4):251-6. PubMed ID: 8750764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA polymorphisms of apolipoprotein A-I/C-III and insulin genes in familial hypertriglyceridemia and coronary heart disease.
    Aalto-Setälä K; Kontula K; Sane T; Nieminen M; Nikkilä E
    Atherosclerosis; 1987 Jul; 66(1-2):145-52. PubMed ID: 3115275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein AI and CIII gene polymorphisms and their association with lipid levels in Italian, Greek and Anglo-Irish populations of Australia.
    Buzza M; Fripp Y; Mitchell RJ
    Ann Hum Biol; 2001; 28(5):481-90. PubMed ID: 11572515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein A-I gene polymorphisms: frequency in patients with coronary artery disease and healthy controls and association with serum apo A-I and HDL-cholesterol concentration.
    Wile DB; Barbir M; Gallagher J; Myant NB; Ritchie CD; Thompson GR; Humphries SE
    Atherosclerosis; 1989 Jul; 78(1):9-18. PubMed ID: 2569310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of association between genetic variability in apolipoprotein (apo) B, apo AI-CIII-AIV, and cholesterol ester transfer protein gene regions and quantitative variation in lipid and lipoprotein traits: influence of gender and exogenous hormones.
    Kessling A; Ouellette S; Bouffard O; Chamberland A; Bétard C; Selinger E; Xhignesse M; Lussier-Cacan S; Davignon J
    Am J Hum Genet; 1992 Jan; 50(1):92-106. PubMed ID: 1346081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA polymorphisms of the apolipoprotein B gene in patients with premature coronary artery disease.
    Genest JJ; Ordovas JM; McNamara JR; Robbins AM; Meade T; Cohn SD; Salem DN; Wilson PW; Masharani U; Frossard PM
    Atherosclerosis; 1990 May; 82(1-2):7-17. PubMed ID: 1972879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [DNA polymorphisms of the apolipoprotein AI-CIII-AIV gene cluster in coronary artery disease].
    Dan Q; Huang Y; Peng Z
    Zhonghua Yi Xue Za Zhi; 1995 Oct; 75(10):584-7, 637. PubMed ID: 8697070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of association between genetic variations of apo A-I-C-III-A-IV gene cluster and myocardial infarction in a sample of European male: ECTIM study.
    Kee F; Amouyel P; Fumeron F; Arveiler D; Cambou JP; Evans A; Cambien F; Fruchart JC; Ducimetière P; Dallongeville J
    Atherosclerosis; 1999 Jul; 145(1):187-95. PubMed ID: 10428310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of association of the apolipoprotein A-I-C-III-A-IV gene XmnI and SstI polymorphisms and of the lipoprotein lipase gene mutations in familial combined hyperlipoproteinemia in French Canadian subjects.
    Marcil M; Boucher B; Gagné E; Davignon J; Hayden M; Genest J
    J Lipid Res; 1996 Feb; 37(2):309-19. PubMed ID: 9026529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA polymorphisms of the apolipoprotein B gene (XbaI, EcoRI, and MspI RFLPs) in Norwegians at risk of atherosclerosis and healthy controls.
    Delghandi M; Thangarajah R; Nilsen M; Grimsgaard S; Bønaa KH; Tonstad S; Jørgensen L
    Acta Cardiol; 1999 Aug; 54(4):215-25. PubMed ID: 10511898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased frequency of the rare PstI allele (P2) in a population of CAD patients in northern Greece.
    Vavatsi NA; Kouidou SA; Geleris PN; Tachmatzidis C; Gikas T; Tsifodimos DK; Trakatellis AC
    Clin Genet; 1995 Jan; 47(1):22-6. PubMed ID: 7774039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of DNA polymorphisms of the apolipoprotein genes to study the role of genetic variation in the determination of serum lipid levels.
    Humphries SE; Talmud PJ; Kessling AM
    Ciba Found Symp; 1987; 130():128-49. PubMed ID: 2894927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.